Julie O'Neill

Julie O’Neill is a business professional with more than two decades of executive experience in senior leadership roles. She was previously Executive Vice President, Global Operations at Alexion Pharmaceuticals. where she led the Global Operations business including product development, manufacturing, quality, supply chain, and global real estate functions. Prior to joining Alexion, she was Vice President of Operations at Gilead Sciences. Ms. O’Neill serves as an Independent Director on the boards of ICON, DBV Technologies Hookipa Pharma, ILC Dover, and Angus Chemical Company. She is also on the Board of Ireland’s National Institute for Bioprocessing Research & Training (NIBRT) and serves on the Strategy Committee of the State Claims Agency in Ireland.